Back

Early dapagliflozin therapy after STEMI in patients with preserved ejection fraction: a prospective cohort study

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - epidemiology, prognosis, outcome (2) Epidemiology, Prognosis, Outcome Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Professor Hamlet Hayrapetyan

Erebouni Medical Center, Yerevan (Armenia)

8 More presentations in this session

Presentation thumbnail
Objectively measured physical inactivity identifies a cardiopulmonary heart failure phenotype in U.S. adults
Doctor L. Alrubaye (Greenville, US)
Abstract
Presentation thumbnail
Expanding biomarker strategies in advanced heart failure: the emerging role of CA-125
Doctor P. Bernardes (Setubal, PT)
Abstract
Presentation thumbnail
Lower appendicular lean mass identifies a skeletal muscle phenotype of heart failure in U.S. adults
Doctor L. Alrubaye (Greenville, US)
Abstract
Presentation thumbnail
Integrating biomarkers and machine learning for early prediction of incident heart failure in older adults: a systematic review and meta-analysis
Miss S. Satishkumar (Tbilisi, GE)
Abstract
Presentation thumbnail
Hidden burden: the impact of durable LVAD support on caregivers
Doctor I. Santos (Ponta Delgada, PT)
Abstract

Access the full session

Session thumbnail
ePosters in chronic heart failure - epidemiology, prognosis, outcome (2)

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources